Research ArticleOriginal Article
Open Access

The rising trend in papillary thyroid carcinoma

True increase or over diagnosis?

Manar H. Hajeer, Heyam A. Awad, Niveen I. Abdullah, Ghadeer H. Almuhaisen and Loay E. Abudalu
Saudi Medical Journal February 2018, 39 (2) 147-153; DOI: https://doi.org/10.15537/smj.2018.2.21211

References

  1. ↵
    1. Siegel RL,
    2. Miller KD,
    3. Jemal A
    (2016) Cancer statistics 2016. CA Cancer J Clin 66:7–30.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Wiltshire JJ,
    2. Drake TM,
    3. Uttley L,
    4. Balasubramanian SP
    (2016) Systematic Review of Trends in the Incidence Rates of Thyroid Cancer. Thyroid 26:1541–1552.
    OpenUrl
  3. ↵
    1. Morris LG,
    2. Sikora AG,
    3. Tosteson TD,
    4. Davies L
    (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23:885–891.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Veiga LH,
    2. Neta G,
    3. Aschebrook-Kilfoy B,
    4. Ron E,
    5. Devesa SS
    (2013) Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program 1997-2008. Thyroid 23:748–757.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Davies L,
    2. Welch HG
    (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 14:317–322.
    OpenUrl
  6. ↵
    1. O'Grady TJ,
    2. Gates MA,
    3. Boscoe FP
    (2015) Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int J Cancer 137:2664–2673.
    OpenUrlCrossRefPubMed
    1. Pandeya N,
    2. McLeod DS,
    3. Balasubramaniam K,
    4. Baade PD,
    5. Youl PH,
    6. Bain CJ,
    7. Allison R,
    8. Jordan SJ
    (2016) Increasing thyroid cancer incidence in Queensland, Australia 1982–2008–true increase or overdiagnosis? Clin endocrinol 84:257–264.
    OpenUrl
  8. ↵
    1. Konturek A,
    2. Barczyński M,
    3. Stopa M,
    4. Nowak W
    (2016) Trends in prevalence of thyroid cancer over three decades: a retrospective cohort study of 17,526 surgical patients. World J Surg 40:538–544.
    OpenUrl
  9. ↵
    1. Yildiz SY,
    2. Berkem H,
    3. Yuksel BC,
    4. Ozel H,
    5. Kendirci M,
    6. Hengirmen S
    (2014) The rising trend of papillary carcinoma in thyroidectomies:14-years of experience in a referral center of Turkey. World J Surg Oncol 12:34.
    OpenUrlCrossRefPubMed
    1. Amphlett B,
    2. Lawson Z,
    3. Abdulrahman GO Jr.,
    4. White C,
    5. Bailey R,
    6. Premawardhana LD,
    7. et al.
    (2013) Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales 1985-2010. Thyroid 23:14708.
    OpenUrl
  11. ↵
    1. Safavi A,
    2. Azizi F,
    3. Jafari R,
    4. Chaibakhsh S,
    5. Safavi AA
    (2016) Thyroid Cancer Epidemiology in Iran: a Time Trend Study. Asian Pac J Cancer Prev 17:407–412.
    OpenUrl
  12. ↵
    1. Hussain F,
    2. Iqbal S,
    3. Mehmood A,
    4. Bazarbashi S,
    5. ElHassan T,
    6. Chaudhri N
    (2013) Incidence of thyroid cancer in the Kingdom of Saudi Arabia 2000-2010. Hematol Oncol Stem Cell Ther 6:58–64.
    OpenUrlCrossRefPubMed
    1. Awad Saad Al Shahrani,
    2. Ashraf El-Metwally,
    3. Khaled Al-Surimi,
    4. Salih Bin Salih,
    5. Yousef Saleh,
    6. Abeer Al-Shehri,
    7. et al.
    (2016) The epidemiology of thyroid diseases in the Arab world: A systematic review. J Public Health Epidemiol 8:17–26.
    OpenUrl
  14. ↵
    1. Al-Zaher N,
    2. Al-Salam S,
    3. El Teraifi H
    (2008) Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital. Hematol Oncol Stem Cell Ther 1:14–21.
    OpenUrlPubMed
  15. ↵
    1. Pathak KA,
    2. Leslie WD,
    3. Klonisch TC,
    4. Nason RW
    (2013) The changing face of thyroid cancer in a population-based cohort. Cancer Med 2:537–544.
    OpenUrl
  16. ↵
    1. Kwon JH,
    2. Kim EK,
    3. Lee HS,
    4. Moon HJ,
    5. Kwak JY
    (2013) Neck ultrasonography as preoperative localization of primary hyperparathyroidism with an additional role of detecting thyroid malignancy. Eur J Radiol 82:e1721.
    OpenUrl
  17. ↵
    1. Furuya-Kanamori L,
    2. Bell KJ,
    3. Clark J,
    4. Glasziou P,
    5. Doi SA
    (2016) Prevalence of differentiated thyroid cancer in autopsy studies over six decades: A meta-analysis. J Clin Oncol 34:3672–3679.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Morris LG,
    2. Myssiorek D
    (2010) Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200:454–461.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Lloyd RV,
    2. Osamura RY,
    3. Klöppel G,
    4. Rosai J
    (2017) Pathology and genetics of tumours of endocrine organs (IARC WHO Classification of Tumours, Geneva (CH)).
  20. ↵
    1. Nixon IJ,
    2. Ganly I,
    3. Patel SG,
    4. Palmer FL,
    5. Whitcher MM,
    6. Ghossein R,
    7. et al.
    (2012) Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg 10:618–623.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Busco S,
    2. Giorgi Rossi P,
    3. Sperduti I,
    4. Pezzotti P,
    5. Buzzoni C,
    6. Pannozzo F
    (2013) Increased incidence of thyroid cancer in Latina, Italy: a possible role of detection of subclinical disease. Cancer Epidemiol 37:262–269.
    OpenUrl
  22. ↵
    1. Altekruse S,
    2. Das A,
    3. Cho H,
    4. Petkov V,
    5. Yu M
    (2015) Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance?An observational study using SEER population-based data. BMJ Open 5:e009843.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Moon HJ,
    2. Lee HS,
    3. Kim EK,
    4. Ko SY,
    5. Seo JY,
    6. Park WJ,
    7. et al.
    (2015) Thyroid nodules ≤5 mm on ultrasonography: are they “leave me alone” lesions? Endocrine 49:735–744.
    OpenUrlPubMed
  24. ↵
    1. Vollmer RT
    (2014) Revisiting overdiagnosis and fatality in thyroid cancer. Am J Clin Pathol 141:128–132.
    OpenUrlCrossRefPubMed
    1. Leboulleux S,
    2. Tuttle RM,
    3. Pacini F,
    4. Schlumberger M
    (2016) Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol 4:933–942.
    OpenUrl
  26. ↵
    1. Vlassopoulou V,
    2. Vryonidou A,
    3. Paschou SA,
    4. Ioannidis D,
    5. Koletti A,
    6. Klonaris N,
    7. et al.
    (2016) No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period. BMC Res Notes 9:252.
    OpenUrl
  27. ↵
    1. Ukrainski MB,
    2. Pribitkin EA,
    3. Miller JL
    (2016) Increasing incidence of thyroid nodules and thyroid cancer: does increased detection of a subclinical reservoir justify the associated anxiety and treatment? Clin Ther 38:976–985.
    OpenUrl
  28. ↵
    1. Pellegriti G,
    2. Frasca F,
    3. Regalbuto C,
    4. Squatrito S,
    5. Vigneri R
    (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Zhang Y,
    2. Chen Y,
    3. Huang H,
    4. Sandler J,
    5. Dai M,
    6. et al.
    (2015) Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev 24:439–446.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section